Info@ThinkPinkRocks.org

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc.

Read More:
United Therapeutics submits pre-market approval application for use of Remodulin with implantable drug infusion system

Scroll to Top